Maravai Lifesciences Holdings Inc Cl A (MRVI)

$2.38 +0.21 (9.68%)
Market Cap 562.80M
Revenue (ttm) 259.19M
Net Income (ttm) -144.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -55.89%
Debt to Equity Ratio 0.56
Volume 1,308,129
Avg Vol 2,091,188
Day's Range N/A - N/A
Shares Out 254.66M
Stochastic %K 23%
Beta 0.25
Analysts Sell
Price Target $5.52

Latest News on MRVI

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out

Jun 5, 2025, 10:00 AM EDT - 1 day ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 3 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 5 days ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation

May 29, 2025, 10:05 AM EDT - 8 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 10 days ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

May 25, 2025, 10:00 AM EDT - 12 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

May 22, 2025, 10:00 AM EDT - 15 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025, 4:22 PM EDT - 15 days ago

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

Maravai LifeSciencesReleases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 16 days ago

Maravai LifeSciencesReleases 2024 Sustainability Report

Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 16 days ago

Maravai LifeSciences Releases 2024 Sustainability Report

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

May 20, 2025, 8:00 AM EDT - 17 days ago

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

May 18, 2025, 10:00 AM EDT - 19 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 15, 2025, 10:00 AM EDT - 22 days ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

May 13, 2025, 1:29 PM EDT - 24 days ago

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation

May 13, 2025, 10:00 AM EDT - 24 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

May 13, 2025, 12:03 AM EDT - 24 days ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

Maravai Lifesciences Reports First Quarter 2025 Financial Results

May 12, 2025, 4:06 PM EDT - 25 days ago

Maravai Lifesciences Reports First Quarter 2025 Financial Results

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

May 11, 2025, 10:00 AM EDT - 26 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

May 8, 2025, 10:00 AM EDT - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

May 5, 2025, 5:47 AM EDT - 4 weeks ago

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

May 1, 2025, 7:30 AM EDT - 5 weeks ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Apr 19, 2025, 7:36 AM EDT - 6 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations – Hagens Berman

Apr 16, 2025, 6:10 PM EDT - 7 weeks ago

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations – Hagens Berman

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman

Apr 15, 2025, 6:00 PM EDT - 7 weeks ago

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Apr 9, 2025, 11:23 AM EDT - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript

Mar 20, 2025, 9:00 PM EDT - 2 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript

Time-Sensitive: Maravai Lifesciences (MRVI) Investors May Have Legal Claims - Act Before May 5 Deadline

Mar 20, 2025, 11:45 AM EDT - 2 months ago

Time-Sensitive: Maravai Lifesciences (MRVI) Investors May Have Legal Claims - Act Before May 5 Deadline

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 18, 2025, 4:05 PM EDT - 2 months ago

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results